健康蛋白质组学指标预测阿尔茨海默病生物标志物水平与痴呆风险
在706名认知正常成人中,14种基于蛋白质的健康指标与血浆AD生物标志物及神经影像标志物相关,并在另一11,285人队列中检验其预测25年痴呆风险的能力。心血管、心力衰竭死亡和肾脏疾病风险较高与Aβ42/40较低及pTau-181、NfL、GFAP较高相关,仅心血管风险指标与区域脑体积减小及25年痴呆风险相关。
要点
- 心血管疾病、心衰死亡和肾病蛋白质风险高与Aβ42/40低及pTau-181、NfL、GFAP高相关。
- 体脂百分比、去脂体重和内脏脂肪蛋白质指标与pTau-181、NfL、GFAP相关,静息能量率与NfL、GFAP负相关。
- 仅心血管风险蛋白质指标与区域脑体积减小及25年痴呆风险相关。
核心结论
- 亚临床外周健康可能影响AD和神经退行性病变过程及相关生物标志物水平,尤其是NfL。
- 心血管健康即使在无临床定义疾病时,也在脑老化和痴呆中起核心作用。
研究设计与样本
- 在706名认知正常成人中,横断面分析14种基于蛋白质的健康指标与同期血浆AD生物标志物、脑体积及皮层Aβ和tau的关联。
- 在另一11,285人队列中,检验与神经退行性病变相关的蛋白质健康指标是否预测25年痴呆风险。
主要发现
- 心血管疾病、心衰死亡和肾病蛋白质风险较高与Aβ42/40较低及pTau-181、NfL、GFAP较高相关,即使在无心血管或肾病个体中亦然。
- 体脂百分比、去脂体重和内脏脂肪蛋白质指标与pTau-181、NfL、GFAP相关,静息能量率与NfL和GFAP负相关。
- 这些健康指标分别预测血浆Aβ42/40、pTau-181、NfL和GFAP水平的12%、31%、50%和33%。
- 仅心血管风险蛋白质指标与区域脑体积减小相关,并预测25年痴呆风险,即使在无临床定义心血管疾病者中亦然。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few studies have comprehensively examined how health and disease risk influence Alzheimer's disease (AD) biomarkers. The present study examined the association of 14 protein-based health indicators with plasma and neuroimaging biomarkers of AD and neurodegeneration. METHODS: In 706 cognitively normal adults, we examined whether 14 protein-based health indices (ie, SomaSignal® tests) were associated with concurrently measured plasma-based biomarkers of AD pathology (amyloid-β [Aβ]42/40 , tau phosphorylated at threonine-181 [pTau-181]), neuronal injury (neurofilament light chain [NfL]), and reactive astrogliosis (glial fibrillary acidic protein [GFAP]), brain volume, and cortical Aβ and tau. In a separate cohort (n = 11,285), we examined whether protein-based health indicators associated with neurodegeneration also predict 25-year dementia risk. RESULTS: Greater protein-based risk for cardiovascular disease, heart failure mortality, and kidney disease was associated with lower Aβ42/40 and higher pTau-181, NfL, and GFAP levels, even in individuals without cardiovascular or kidney disease. Proteomic indicators of body fat percentage, lean body mass, and visceral fat were associated with pTau-181, NfL, and GFAP, whereas resting energy rate was negatively associated with NfL and GFAP. Together, these health indicators predicted 12, 31, 50, and 33% of plasma Aβ42/40 , pTau-181, NfL, and GFAP levels, respectively. Only protein-based measures of cardiovascular risk were associated with reduced regional brain volumes; these measures predicted 25-year dementia risk, even among those without clinically defined cardiovascular disease. INTERPRETATION: Subclinical peripheral health may influence AD and neurodegenerative disease processes and relevant biomarker levels, particularly NfL. Cardiovascular health, even in the absence of clinically defined disease, plays a central role in brain aging and dementia. ANN NEUROL 2024;95:260-273.
引用
- Dark HE, Paterson C, Daya GN, et al. Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk. Ann Neurol. 2023. PMID: 37801487. doi:10.1002/ana.26817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。